One such inhibitor, amantadine, a licensed anti-influenza drug, was shown to significantly inhibit CTSL activity after SARS-CoV-2 pseudovirus infection by suppressing transcription of the CTSL-encoding gene to prevent SARS-CoV-2 infection both in vitro and in vivo [74,75,76]. The gene discussed is CTSL; the disease is influenza.